全关节置换术围手术期静脉使用糖皮质激素与术后感染风险:系统综述与荟萃分析
该系统综述与荟萃分析纳入29项比较性研究,评估全关节置换术围手术期静脉使用糖皮质激素与术后感染风险的关系。结果显示单次低剂量、单次高剂量及重复低剂量方案均未增加感染风险,髋或膝关节置换中亦无显著风险差异,但研究间患者特征存在异质性。
要点
- 单次高剂量及重复低剂量方案均未显示感染风险增加。
- 髋或膝关节置换中感染风险差异无统计学意义。
核心结论
- 在合并症有限的患者中,全关节置换术围手术期使用糖皮质激素似乎不增加术后感染风险。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Google Scholar和EMBASE(2021年1月),纳入29项比较性研究,遵循PRISMA指南。
主要发现
- 评估重复高剂量方案的研究报告无感染增加,但纳入参与者数量少。
临床怎么用
- 对于合并症有限的全关节置换术患者,围手术期静脉使用糖皮质激素可能不增加术后感染风险。
局限性
- 纳入研究的患者特征存在异质性。
- 评估重复高剂量方案的研究纳入参与者数量少。
- 需要进一步研究评估高风险患者群体中的术后并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative corticosteroid administration is associated with reduced postoperative nausea, pain, and enhanced recovery after surgery. However, potential complications including wound and periprosthetic joint infections remain a concern for surgeons after total joint arthroplasty (TJA). METHODS: A systematic review of the search databases PubMed, Google Scholar, and EMBASE was made in January 2021 to identify comparative studies evaluating infection risk after perioperative corticosteroid administration in TJA. PRISMA guidelines were used for this review. Meta-analysis was used to assess infection risk in accordance with joint and corticosteroid dosing regimen used. RESULTS: 201 studies were returned after initial search strategy, with 29 included for review after application of inclusion and exclusion criteria. Studies were categorized as using low- or high-dose corticosteroid with single or repeat dosing regimens. Single low-dose corticosteroid administration was not associated with an increased risk of infection (P = .4; CI = 0.00-0.00). Single high-dose corticosteroid was not associated with an increased infection risk (P = .3; CI = 0.00-0.01) nor did repeat low-dose regimens result in increased risk of infection (P = .8; CI = -0.02-0.02). Studies assessing repeat high-dosing regimens reported no increased infection, with small numbers of participants included. No significant risk difference in infection risk was noted in hip (P = .59; CI = -0.03-0.02) or knee (P = .2; CI = 0.00-0.01) arthroplasty. Heterogeneity in patient profiles included in studies to date was noted. CONCLUSION: Use of perioperative corticosteroid in TJA does not appear to be associated with increased risk of postoperative infection in patients with limited comorbidities. Further research is warranted to evaluate postoperative complications after TJA in these at-risk patient populations.
引用
- Feeley AA, Feeley TB, Feeley IH, et al. Postoperative Infection Risk in Total Joint Arthroplasty After Perioperative IV Corticosteroid Administration: A Systematic Review and Meta-Analysis of Comparative Studies. J Arthroplasty. 2021. PMID: 33902983. doi:10.1016/j.arth.2021.03.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。